v-src induces clonal sarcomas and rapid metastasis following transduction with a replication-defective retrovirus.

AUTOR(ES)

Stoker, A W

RESUMO

v-src is an effective carcinogen when expressed from Rous sarcoma virus (RSV) in vivo. Whereas RSV tumors require sustained oncogene expression, their growth is largely a balance between viral recruitment of tissues and host immune destruction of infected cells. We have therefore examined the tumorigenic potential of v-src in the absence of viral recruitment and viral antigen expression. v-src was introduced with high efficiency into chicken wing web tissues using replication-defective (rd) retroviral vectors. Clonal sarcomas were induced rapidly, and, furthermore, v-src potentiated metastatic progression in approximately 0.1%-1% of tumor clones with unexpectedly short latency. rd vectors proved effective not only in transducing v-src into tissues but also as insertional markers of tumor clonality. The rd vector present in most primary and metastatic tumors was a highly truncated form of RSV derived by viral transmission of spliced v-src mRNA; this vector should thus avoid viral recruitment and host anti-viral immune reaction through its complete lack of viral structural genes. Under such conditions v-src maintains strong carcinogenicity in vivo when restricted to clonal tumor growth and can confer rapid metastatic potential on a discrete subset of tumor clones.

Documentos Relacionados

• Genetic analysis of myeloproliferative leukemia virus, a novel acute leukemogenic replication-defective retrovirus.
• Gene targeting with a replication-defective adenovirus vector.
• Ras-independent transformation by v-Src
• Activation of YRP kinase by v-Src and protein kinase C-mediated signal transduction pathways.
• Replication-Defective Vector Based on a Chimpanzee Adenovirus